Patents Assigned to ASPIRA WOMEN'S HEALTH INC.
  • COMPOSITIONS FOR OVARIAN CANCER ASSESSMENT HAVING IMPROVED SPECIFICITY AND SENSITIVITY
    Publication number: 20230127069
    Abstract: The present invention provides compositions and methods having improved specificity and sensitivity for the pre-operative assessment of ovarian tumors (e.g., symptomatic and asymptomatic adnexal mass) in a variety of subjects (e.g., pre- and post-menopausal women) having a variety of ovarian cancer types (e.g., low malignant potential, intermediate malignant potential, high malignant potential).
    Type: Application
    Filed: September 19, 2022
    Publication date: April 27, 2023
    Applicant: Aspira Women's Health Inc.
    Inventors: Herbert FRITSCHE, Lesley NORTHROP
  • COMPOSITIONS FOR ENDOMETRIOSIS ASSESSMENT HAVING IMPROVED SPECIFICITY
    Publication number: 20230086542
    Abstract: The present invention provides compositions and methods that provide a high degree of sensitivity and a high degree of specificity for the non-invasive assessment of endometriosis in women having a variety of endometriosis types (e.g., endometriosis, endometriotic cysts, endometrioma, or another benign condition of the endometrium) and at a variety of disease states (e.g., early and late stage).
    Type: Application
    Filed: February 18, 2021
    Publication date: March 23, 2023
    Applicant: Aspira Women's Health Inc.
    Inventors: Nitin BHARDWAJ, Todd PAPPAS, Herbert FRITSCHE
  • BIOMARKERS FOR OVARIAN CANCER CTAP3-RELATED PROTEINS
    Publication number: 20220317126
    Abstract: The present invention provides a protein-based biomarker that is useful in qualifying ovarian cancer status in a patient. In particular, the biomarker of this invention is useful to classify a subject sample as ovarian cancer or non-ovarian cancer. The biomarker can be detected by SELDI mass spectrometry.
    Type: Application
    Filed: December 17, 2021
    Publication date: October 6, 2022
    Applicants: Aspira Women's Health Inc., The Johns Hopkins University
    Inventors: Zhen ZHANG, Daniel W. CHAN, Eric T. FUNG, Zheng WANG, Fujun ZHANG
  • Biomarkers for ovarian cancer CTAP3-related proteins
    Patent number: 11255857
    Abstract: The present invention provides a protein-based biomarker that is useful in qualifying ovarian cancer status in a patient. In particular, the biomarker of this invention is useful to classify a subject sample as ovarian cancer or non-ovarian cancer. The biomarker can be detected by SELDI mass spectrometry.
    Type: Grant
    Filed: November 10, 2017
    Date of Patent: February 22, 2022
    Assignees: Aspira Women's Health Inc., The Johns Hopkins University
    Inventors: Zhen Zhang, Daniel W. Chan, Eric T. Fung, Zheng Wang, Fujun Zhang
  • COMPOSITIONS FOR OVARIAN CANCER ASSESSMENT
    Publication number: 20210215701
    Abstract: The present invention provides compositions and methods that provide a high degree of sensitivity and a high degree of specificity for the preoperative assessment of ovarian tumors in an African American subject (e.g., pre- and post-menopausal women) having a variety of ovarian cancer types (e.g., clear cell/mucinous, low malignant potential, high malignant potential) and at a variety of disease states (e.g., early and late stage).
    Type: Application
    Filed: August 13, 2019
    Publication date: July 15, 2021
    Applicant: Aspira Women's Health Inc.
    Inventors: Charles Dunton, Rowan Bullock, Herbert Fritsche
  • Biomarkers for Ovarian Cancer: B2 Microglobulin
    Publication number: 20210181207
    Abstract: The present invention provides protein-based biomarkers and biomarker combinations that are useful in qualifying ovarian cancer status in a patient. In particular, the biomarkers of this invention are useful to classify a subject sample as ovarian cancer or non-ovarian cancer. The biomarkers can be detected by SELDI mass spectrometry.
    Type: Application
    Filed: December 14, 2020
    Publication date: June 17, 2021
    Applicants: ASPIRA WOMEN'S HEALTH INC., THE JOHNS HOPKINS UNIVERSITY
    Inventors: ERIC THOMAS FUNG, ENRIQUE DALMASSO, VLADIMIR PODUST, ZHENG WANG, Zhen Zhang